Neil O'Neill Gilmore, EVP, R&D & CMO at Sarepta Therapeutics, holds 29.07K shares in Sarepta Therapeutics (Ticker: SRPT), holds ― shares in Unity Biotechnology (Ticker: UBX), holds ― shares in Aptinyx (Ticker: APTX).

See the Hottest Stocks Based on Insider Trading >

Neil O'Neill Gilmore
Sarepta Therapeutics (SRPT)
EVP, R&D & CMO

Not Ranked

Neil O'Neill Gilmore has not reported sufficient informative transactions and therefore cannot be ranked.

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

68.24%

SRPT

31.76%

EDIT

0.00%

UBX

A breakdown of Neil O'Neill Gilmore's holdings

See the Top Stocks by Insiders

Insider Roles

Sarepta Therapeutics
(SRPT)

EVP, R&D & CMO

Editas Medicine
(EDIT)

CEO, Director

Unity Biotechnology
(UBX)

Director

Roles that Neil O'Neill Gilmore holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Currently, no data available

The most profitable trade made by Neil O'Neill Gilmore

See the Latest Stocks Traded by Insiders

Neil O'Neill Gilmore's Trading History

SRPT

Sarepta Therapeutics

Mar 05, 2021

EVP, R&D & CMO

Uninformative Buy

―

$3.74M

UBX

Unity Biotechnology

―

Director

―

APTX

Aptinyx

―

EDIT

Editas Medicine

Mar 05, 2024

CEO, Director

Uninformative Buy

―

$1.74M

List of latest transactions for each holding click on a transaction to see Neil O'Neill Gilmore's performance on stock

See All Insider Trading from Today

Neil O'Neill Gilmore insider profile FAQ

What is the percentage of profitable transactions made by Neil O'Neill Gilmore?

The percentage of profitable transactions made by Neil O'Neill Gilmore is ―.

What is the average return per transaction made by Neil O'Neill Gilmore?

The average return per transaction made by Neil O'Neill Gilmore is ―.

What stocks does Neil O'Neill Gilmore hold?

Neil O'Neill Gilmore holds: SRPT, UBX, APTX, EDIT stocks.

What was Neil O'Neill Gilmore’s latest transaction?

Neil O'Neill Gilmore latest transaction was an Uninformative Buy of ―.

What was Neil O'Neill Gilmore's most profitable transaction?

Neil O'Neill Gilmore’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.

What is Neil O'Neill Gilmore's role in Sarepta Therapeutics?

Neil O'Neill Gilmore's role in Sarepta Therapeutics is EVP, R&D & CMO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Neil O'Neill Gilmore Insider Profile

Neil O'Neill Gilmore Sarepta Therapeutics (SRPT)EVP, R&D & CMO